|
Volumn 3, Issue 4, 2012, Pages 200-201
|
Natural products derived from plants as a source of drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
APOMORPHINE;
CAMPTOTHECIN;
CANNABIDIOL;
CANNABIS;
DRONABINOL;
GALANTAMINE;
HERBACEOUS AGENT;
MORPHINE;
PACLITAXEL;
PLANT MEDICINAL PRODUCT;
SILYMARIN;
TIOTROPIUM BROMIDE;
ALZHEIMER DISEASE;
ARTEMISIA ANNUA;
ATHEROSCLEROSIS;
ATROPA BELLADONNA;
BIOLOGICAL ACTIVITY;
BREAST CANCER;
CALLISTEMON CITRINUS;
CAPSICUM ANNUUM;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COLEUS FORSKOHLII;
COST EFFECTIVENESS ANALYSIS;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SYNTHESIS;
EDITORIAL;
ETHNOPHARMACOLOGY;
GALANTHUS NIVALIS;
HERBAL MEDICINE;
HUMAN;
LIVER DISEASE;
LUNG CANCER;
MEDICINAL PLANT;
NONHUMAN;
OBESITY;
OVARY CANCER;
PAIN;
PAPAVER SOMNIFERUM;
PARKINSON DISEASE;
PRIORITY JOURNAL;
SALIX ALBA;
SILYBUM MARIANUM;
STEPHANIA GLABRA;
TAXUS BREVIFOLIA;
|
EID: 84881155541
PISSN: 22314040
EISSN: 09762094
Source Type: Journal
DOI: 10.4103/2231-4040.104709 Document Type: Editorial |
Times cited : (566)
|
References (0)
|